ABclonal Technology

Ribonuclease A (RNase A), molecular weight 13.7 kDa, is an endonuclease that specifically acts on the 3′ end of the pyrimidine residue on RNA, cleaving phosphodiester bonds formed with adjacent nucleotides, and the final product of the reaction is pyrimidine 3′ phosphate and an oligonucleotide with pyrimidine 3′ phosphate at the end. RNase A does not work on DNA.This product is sourced from bovine pancreas and is supplied in the form of white lyophilized powder with enzyme activity ≥ 50 Kunitz units/mg protein.
Its recommended working concentration is 1-100 μg/mL, which will vary depending on specific applications.

RNase H (Ribonuclease H) is an endoribonuclease that specifically hydrolyzes the phosphodiester bonds of RNA which is hybridized to DNA. This enzyme does not digest single or double-stranded DNA.

RNase H (Ribonuclease H) is an endoribonuclease that specifically hydrolyzes the phosphodiester bonds of RNA which is hybridized to DNA. This enzyme does not digest single or double-stranded DNA.

RNase H2 is an endonuclease that preferentially cleaves the 5’ end of ribonucleotides embedded in dsDNA, generating a 5’ phosphate and a 3’ hydroxy terminus. It can also introduce multiple cleavage sites along the RNA portion of the Okazaki fragments.

RNase H2 is an endonuclease that preferentially cleaves the 5’ end of ribonucleotides embedded in dsDNA, generating a 5’ phosphate and a 3’ hydroxy terminus. It can also introduce multiple cleavage sites along the RNA portion of the Okazaki fragments.

RNase Inhibitor, Mammalian specifically inhibits RNases A, B and C. It inhibits RNases by binding noncovalently in a 1:1 ratio with high affinity. It is not effective against RNase 1, RNase T1, S1 Nuclease, RNase H or RNase from Aspergillus. In addition, no inhibition of polymerase activity is observed when RNase Inhibitor is used with Taq DNA Polymerase, AMV or M-MuLV Reverse Transcriptases, or Phage RNA Polymerases (SP6, T7, or T3).
The 50 kDa protein inhibits RNases by binding noncovalently in a 1:1 ratio with an association constant greater than 10¹⁴.

RNase Inhibitor, Mammalian specifically inhibits RNases A, B and C. It inhibits RNases by binding noncovalently in a 1:1 ratio with high affinity. It is not effective against RNase 1, RNase T1, S1 Nuclease, RNase H or RNase from Aspergillus. In addition, no inhibition of polymerase activity is observed when RNase Inhibitor is used with Taq DNA Polymerase, AMV or M-MuLV Reverse Transcriptases, or Phage RNA Polymerases (SP6, T7, or T3).
The 50 kDa protein inhibits RNases by binding noncovalently in a 1:1 ratio with an association constant greater than 10¹⁴.

RNase Inhibitor, Mammalian has a molecular weight of 50 kD and can efficiently non-covalently bind to RNase A, B, and C in a 1:1 ratio, effectively inhibiting the activity of these enzymes, with a binding constant greater than 10^14. This product does not inhibit the activity of RNase 1, RNase T1, S1 nuclease, RNase H, or RNases derived from the Aspergillus genus. Furthermore, RNase Inhibitor, Mammalian does not inhibit the activity of the following polymerases when used in conjunction: Taq DNA polymerase, AMV or M-MuLV reverse transcriptase, and bacteriophage RNA polymerases (such as SP6, T7, or T3). This product is a high-concentration RNase inhibitor that, when used in conjunction with a glycerol-free dilution solution, can be applied for lyophilized reactions.

RNase Inhibitor, Mammalian has a molecular weight of 50 kD and can efficiently non-covalently bind to RNase A, B, and C in a 1:1 ratio, effectively inhibiting the activity of these enzymes, with a binding constant greater than 10^14. This product does not inhibit the activity of RNase 1, RNase T1, S1 nuclease, RNase H, or RNases derived from the Aspergillus genus. Furthermore, RNase Inhibitor, Mammalian does not inhibit the activity of the following polymerases when used in conjunction: Taq DNA polymerase, AMV or M-MuLV reverse transcriptase, and bacteriophage RNA polymerases (such as SP6, T7, or T3). This product is a high-concentration RNase inhibitor that, when used in conjunction with a glycerol-free dilution solution, can be applied for lyophilized reactions.

application (WB, ELISA) & cross reactivity (Mouse)

application (WB, ELISA) & cross reactivity (Mouse)

application (WB, IHC-P, ELISA) & cross reactivity (Human, Mouse)

application (WB, IHC-P, ELISA) & cross reactivity (Human, Mouse)

application (WB, IF-P, ELISA) & cross reactivity (Human, Mouse)

application (WB, IF-P, ELISA) & cross reactivity (Human, Mouse)

application (WB, IF-P, IHC-P, ELISA) & cross reactivity (Human, Mouse, Rat)

application (WB, IF-P, IHC-P, ELISA) & cross reactivity (Human, Mouse, Rat)

application (IHC-P, ELISA) & cross reactivity (Human)

application (IHC-P, ELISA) & cross reactivity (Human)

application (WB, ELISA) & cross reactivity (Human, Rat)

application (WB, ELISA) & cross reactivity (Human, Rat)

application (WB, IF-P, IHC-P, ELISA) & cross reactivity (Human, Mouse, Rat)

application (WB, IF-P, IHC-P, ELISA) & cross reactivity (Human, Mouse, Rat)

application (WB, ELISA) & cross reactivity (Human, Mouse, Rat)

application (WB, ELISA) & cross reactivity (Human, Mouse, Rat)

application (WB, IF/ICC, ELISA) & cross reactivity (Human, Rat)

application (WB, IF/ICC, ELISA) & cross reactivity (Human, Rat)

application (WB, ELISA) & cross reactivity (Human)

application (WB, ELISA) & cross reactivity (Human)

application (WB, IF/ICC, ELISA) & cross reactivity (Mouse, Rat)

application (WB, IF/ICC, ELISA) & cross reactivity (Mouse, Rat)

application (WB, IHC-P, IF/ICC, ELISA) & cross reactivity (Human, Mouse, Rat)

application (WB, IHC-P, IF/ICC, ELISA) & cross reactivity (Human, Mouse, Rat)

application (WB, IF/ICC, ELISA) & cross reactivity (Human, Mouse, Rat)

application (WB, IF/ICC, ELISA) & cross reactivity (Human, Mouse, Rat)

application (WB, ELISA) & cross reactivity (Mouse, Rat)

application (WB, ELISA) & cross reactivity (Mouse, Rat)

application (WB, ELISA) & cross reactivity (Mouse, Rat)

application (WB, ELISA) & cross reactivity (Mouse, Rat)

application (WB, ELISA) & cross reactivity (Human, Mouse)

application (WB, ELISA) & cross reactivity (Human, Mouse)

application (WB, ELISA) & cross reactivity (Rat)

application (WB, ELISA) & cross reactivity (Rat)

application (WB, ELISA) & cross reactivity (Human)

application (WB, ELISA) & cross reactivity (Human)

application (WB, ELISA) & cross reactivity (Human, Mouse)

application (WB, ELISA) & cross reactivity (Human, Mouse)

application (WB, IHC-P, IF/ICC, ELISA) & cross reactivity (Human, Mouse, Rat)

application (WB, IHC-P, IF/ICC, ELISA) & cross reactivity (Human, Mouse, Rat)

application (WB, IHC-P, ELISA) & cross reactivity (Human, Mouse, Rat)